Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05775900
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2023-02-25
Brief Title:
Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRASBRAF Wild-type Metastatic Colorectal Cancer
Sponsor:
Organization:
Sun Yat-sen University